Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling organ-specific metabolism of <i>Citrus clementina</i>.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

A genome-scale metabolic model for the denitrifying bacterium Thauera sp. MZ1T accurately predicts degradation of pollutants and production of polymers.

PLoS computational biology·2025
Same author

Mixotrophic growth of a ubiquitous marine diatom.

Science advances·2024
Same author

Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus.

Tuberculosis (Edinburgh, Scotland)·2024
Same author

Optimizing Virtual Health Technologies Through a Performance-based Readiness Model: Lessons From the Field Deployment of National Emergency Tele-Critical Care Network.

Military medicine·2023
Same author

Project APRED: A web-based data analytics platform for supporting community disaster resilience.

Journal of emergency management (Weston, Mass.)·2023
Same journal

Computational design of low-volatility lubricants for space using interpretable machine learning.

Journal of cheminformatics·2026
Same journal

OpenStats: how to combine statistics and research data management (RDM) to leverage efficient scientific data analysis by guided statistics.

Journal of cheminformatics·2026
Same journal

Unified heterogeneity-aware benchmark of drug synergy prediction: a cross-study analysis of traditional machine learning and graph deep learning models.

Journal of cheminformatics·2026
Same journal

Count your bits: fingerprint benchmarking to assess broad chemical space representation.

Journal of cheminformatics·2026
Same journal

Sampling out-of-distribution chemical spaces via Bayesian flow.

Journal of cheminformatics·2026
Same journal

Hold on tight: the kinetic profiling of opioid receptor ligands using the CORAL-MD.

Journal of cheminformatics·2026
See all related articles

Related Experiment Video

Updated: May 22, 2026

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

In-silico predictive mutagenicity model generation using supervised learning approaches.

Abhik Seal1, Anurag Passi, Uc Abdul Jaleel

  • 1Indiana University Bloomington School of Informatics and Computing, Bloomington, USA. abseal@indiana.edu.

Journal of Cheminformatics
|May 17, 2012
PubMed
Summary
This summary is machine-generated.

This study developed accurate in silico models for predicting chemical mutagenicity using machine learning. Random Forest models demonstrated superior performance, offering a faster and cost-effective alternative to experimental screening for drug discovery.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Related Experiment Videos

Last Updated: May 22, 2026

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Area of Science:

  • Computational chemistry and cheminformatics
  • Toxicology and drug safety assessment
  • Machine learning applications in bioinformatics

Background:

  • Experimental screening for chemical biological activity is costly and time-consuming.
  • In silico predictive models offer rapid virtual screening to prioritize compounds.
  • Previous mutagenicity prediction focused on toxicophores, not whole-molecule models.

Purpose of the Study:

  • To evaluate various in silico classification models for predicting compound mutagenicity.
  • To apply machine learning methods like J48 and SMO in cheminformatics for mutagenicity prediction.
  • To develop and validate accurate predictive models for mutagenic properties.

Main Methods:

  • Utilized Bursi (Set 1) and Benchmark (Set 2) mutagenicity datasets, combined into Set 3.
  • Employed classification algorithms: Naïve Bayes, Random Forest, J48, and SMO with 10-fold cross-validation.
  • Validated models on external datasets (AID1189, AID1194) and applied to DrugBank and Zinc databases.

Main Results:

  • The combined dataset (Set 3) yielded better model performance than Set 2 alone.
  • Random Forest achieved the highest accuracy (89.27%), precision (89%), and ROC (95.3%) on Set 3.
  • External validation showed robust performance, with one test achieving 91% accuracy, 91% precision, and 96.3% ROC.

Conclusions:

  • A novel mutagenicity benchmark dataset of approximately 8,000 compounds was created.
  • Highly accurate machine learning models for mutagenicity prediction were developed, complementing toxicophore-based methods.
  • Random Forest models consistently outperformed other machine learning methods for this predictive task.